NEOS Investment Management LLC Has $1.58 Million Stock Position in Masimo Co. (NASDAQ:MASI)

NEOS Investment Management LLC decreased its holdings in shares of Masimo Co. (NASDAQ:MASI - Free Report) by 34.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,580 shares of the medical equipment provider's stock after selling 5,030 shares during the quarter. NEOS Investment Management LLC's holdings in Masimo were worth $1,584,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the business. Vanguard Group Inc. raised its position in shares of Masimo by 1.5% during the 4th quarter. Vanguard Group Inc. now owns 4,586,702 shares of the medical equipment provider's stock valued at $758,182,000 after acquiring an additional 66,215 shares during the last quarter. LPL Financial LLC increased its holdings in Masimo by 22.9% in the fourth quarter. LPL Financial LLC now owns 4,310 shares of the medical equipment provider's stock valued at $712,000 after purchasing an additional 803 shares during the last quarter. KLP Kapitalforvaltning AS acquired a new position in Masimo in the fourth quarter valued at about $1,554,000. American Century Companies Inc. boosted its holdings in Masimo by 12.2% during the fourth quarter. American Century Companies Inc. now owns 12,659 shares of the medical equipment provider's stock worth $2,093,000 after buying an additional 1,374 shares during the last quarter. Finally, Virtu Financial LLC acquired a new position in shares of Masimo during the 4th quarter worth about $244,000. Institutional investors and hedge funds own 85.96% of the company's stock.

Analyst Ratings Changes

A number of brokerages recently issued reports on MASI. Needham & Company LLC restated a "hold" rating on shares of Masimo in a report on Wednesday, February 26th. Raymond James boosted their price target on shares of Masimo from $170.00 to $194.00 and gave the company an "outperform" rating in a report on Friday, December 27th. Piper Sandler raised their price objective on Masimo from $210.00 to $215.00 and gave the stock an "overweight" rating in a research note on Wednesday, February 26th. Finally, Wells Fargo & Company boosted their target price on Masimo from $193.00 to $205.00 and gave the company an "overweight" rating in a research note on Wednesday, February 26th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to data from MarketBeat, Masimo presently has a consensus rating of "Moderate Buy" and an average price target of $194.80.

Remove Ads

Masimo Stock Up 0.6 %

Shares of MASI stock traded up $1.01 during trading hours on Tuesday, hitting $167.61. 373,879 shares of the company were exchanged, compared to its average volume of 638,636. Masimo Co. has a 52 week low of $101.61 and a 52 week high of $194.88. The company has a current ratio of 2.01, a quick ratio of 1.11 and a debt-to-equity ratio of 0.50. The business has a 50 day moving average of $174.67 and a two-hundred day moving average of $162.10. The company has a market capitalization of $9.06 billion, a PE ratio of 115.59 and a beta of 1.04.

Masimo (NASDAQ:MASI - Get Free Report) last released its earnings results on Tuesday, February 25th. The medical equipment provider reported $1.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.42 by $0.38. The firm had revenue of $600.70 million during the quarter, compared to analysts' expectations of $593.35 million. Masimo had a return on equity of 14.98% and a net margin of 3.85%. Analysts anticipate that Masimo Co. will post 4.1 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, COO Bilal Muhsin sold 30,000 shares of the stock in a transaction on Monday, March 10th. The shares were sold at an average price of $167.49, for a total transaction of $5,024,700.00. Following the completion of the transaction, the chief operating officer now owns 24,172 shares in the company, valued at approximately $4,048,568.28. This represents a 55.38 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Craig B. Reynolds sold 2,053 shares of Masimo stock in a transaction on Friday, March 14th. The shares were sold at an average price of $166.13, for a total transaction of $341,064.89. Following the completion of the sale, the director now owns 16,581 shares in the company, valued at $2,754,601.53. The trade was a 11.02 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 9.70% of the stock is owned by corporate insiders.

Masimo Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.